|
EIF5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.47950035240308E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13590004069408E-09 |
| Normal-vs-Stage2 |
1.043390E-03 |
| Normal-vs-Stage3 |
5.764800E-04 |
| Normal-vs-Stage4 |
4.23589999998253E-06 |
| Stage1-vs-Stage2 |
8.195600E-01 |
| Stage1-vs-Stage3 |
6.966200E-01 |
| Stage1-vs-Stage4 |
4.736400E-01 |
| Stage2-vs-Stage3 |
9.279400E-01 |
| Stage2-vs-Stage4 |
4.325400E-01 |
| Stage3-vs-Stage4 |
4.075600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.99119951030491E-10 |
| Normal-vs-AfricanAmerican |
1.86219999998016E-06 |
| Normal-vs-Asian |
3.960600E-03 |
| Caucasian-vs-AfricanAmerican |
4.191000E-01 |
| Caucasian-vs-Asian |
7.699400E-01 |
| AfricanAmerican-vs-Asian |
9.989000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22099996779923E-10 |
| Normal-vs-Female |
4.44250000000146E-05 |
| Male-vs-Female |
9.721600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.95680000000453E-05 |
| Normal-vs-Extreme_Weight |
5.50040013536091E-11 |
| Normal-vs-Obese |
2.43659999998869E-06 |
| Normal-vs-Extreme_Obese |
3.917800E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.781780E-01 |
| Normal_Weight-vs-Obese |
7.318400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.259000E-01 |
| Extreme_Weight-vs-Obese |
4.526300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.935600E-01 |
| Obese-vs-Extreme_Obese |
1.788190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63595000000072E-05 |
| Normal-vs-Age(41-60Yrs) |
5.15189999994448E-07 |
| Normal-vs-Age(61-80Yrs) |
4.69879690712105E-11 |
| Normal-vs-Age(81-100Yrs) |
1.2630000000291E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.167000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.922400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.324400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.624200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.111420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.387600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.333399946013E-09 |
| Normal-VS-Type2 PRCC |
9.52150003286079E-09 |
| Normal-VS-KIRP CIMP |
3.69719999948614E-07 |
| Normal-VS-Unclassified PRCC |
1.978260E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.785400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.121790E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.372000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.774200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.418200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.208780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59899871121638E-11 |
| Normal-vs-N1 |
2.369800E-04 |
| Normal-vs-N2 |
1.62436730732907E-12 |
| N0-vs-N1 |
1.553640E-01 |
| N0-vs-N2 |
1.68298708302927E-12 |
| N1-vs-N2 |
1.69839999952792E-07 |
|
|
